ohr set to begin phase iii trials for wet amd (ois@aao 2016)
Published 7 years ago • 384 plays • Length 7:32Download video MP4
Download video MP3
Similar videos
-
7:09
notal helps foresee wet amd (ois@aao 2016)
-
14:58
catch up on ois@aao’s year in review (ois@aao 2016)
-
7:05
graybug builds team, advances pipeline (ois@aao 2016)
-
7:17
ohr pharmaceutical to release top-line phase iii trials early 2018
-
8:05
adverum biotechnologies gains momentum in gene therapy (ois@aao 2016)
-
7:30
tracery drawing finer lines for amd (ois@aao 2016)
-
3:26
opthea taking new approach to combat wet amd
-
5:57
nei pursues innovation on multiple tracks (ois@aao 2016)
-
7:32
allegro ophthalmics - ois@aao 2015
-
7:28
novaliq: transforming tears (ois@aao 2016)
-
7:03
ocular therapeutix’s depot programs move forward (ois@aao 2016)
-
8:23
psivida: sustained-release therapies (ois@aao 2016)
-
7:58
a view from the aao - ois@aao 2015
-
10:22
regenxbio: aav gene therapy company with 4 internal clinical-stage programs
-
7:03
translatum medicus - ois@aao 2015
-
6:08
allegro ophthalmics preps for phase iii of risuteganib
-
7:19
iconic therapeutics - ois@aao 2015
-
8:42
gyroscope therapeutics - gene & cell therapy spotlight at ois @ aao 2019
-
3:06
allegro’s karageozian (ois@aao 2016)